Cover Image
市場調查報告書

生命科學、化學領域的各種設備的全球市場 (∼2019年):層析法、電泳、DNA定序器、PCR、微量盤式分析儀、機器人工學、光譜學、免疫測量、微陣列、流式細胞儀、培養箱、通風罩、離心機

Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019

出版商 MarketsandMarkets 商品編碼 327896
出版日期 內容資訊 英文 258 Pages
訂單完成後即時交付
價格
Back to Top
生命科學、化學領域的各種設備的全球市場 (∼2019年):層析法、電泳、DNA定序器、PCR、微量盤式分析儀、機器人工學、光譜學、免疫測量、微陣列、流式細胞儀、培養箱、通風罩、離心機 Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019
出版日期: 2015年03月31日 內容資訊: 英文 258 Pages
簡介

全球生命科學、化學領域的各種設備的市場預計從2014年到2019年以6.9%的年複合成長率成長,2019年達到488億4000萬美元的規模。分析設備的技術性進步,政府對新興國家的醫藥品R&D的支出擴大,國家及民間對生命科學領域的R&D的支出擴大,食的安全受到高度的關注,藥物研發及臨床診斷領域的進步等成為促使該市場成長的要素。另外專業白質組學市場成長,對環境安全的擔憂擴大,來自終端用途市場的分析設備的需求擴大等成為帶給加入經營者市場機會的主要原因。可是同時,設備的高成本性和替代技術的存在,有專門技術的人力資源的必要性等成為阻礙這個成長的要素。

本報告提供全球生命科學、化學領域的各種設備的市場相關調查、主要的技術及設備種類與概要、各設備區分及終端用戶的市場趨勢及市場成長預測、各地區及主要國家趨勢、主要的影響市場成長因素及市場機會分析、競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 富有魅力的市場機會
  • 4大地區市場
  • 各技術市場預測

第5章 市場概要

  • 簡介
  • 市場發展
  • 市場區隔
    • 各技術
    • 各終端用戶
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 產業分析

  • 簡介
  • 價值鏈分析
  • 產業趨勢
    • 小型的設備的開發
    • 串聯技術的引進擴大
    • 分析設備製造商和調查實驗室及學術機構的聯合
  • 波特的五力分析

第7章 各技術市場

  • 簡介
  • 層析法
    • 成長推進因素
    • 阻礙成長要素
    • 課題
    • 各類型市場
      • 液體層析法
      • 氣相層析法
      • 其他層析法技術
    • 主要企業的市場佔有率分析
  • 電泳
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • 凝膠電泳
      • 毛細管電泳法
    • 主要企業的市場佔有率分析
  • DNA定序器&增幅器
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • DNA定序器
      • DNA增幅器
        • 聚合酵素連鎖反應熱循環儀
        • 即時PCR
        • 其他
    • 主要企業的市場佔有率分析
  • 實驗室自動化
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • 自動液體分注儀
      • 微量盤式分析儀
      • 獨立式機器人
      • ASRS (自動存儲、搜索系統)
      • 軟體、資訊學
      • 其他
    • 主要企業的市場佔有率分析
  • 光譜學
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • 分子光譜
      • 原子光譜
      • 質譜
    • 主要企業的市場佔有率分析
  • 免疫測量
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • EIA (酵素免疫分析法)
      • FIA (螢光免疫分析法)
      • Clia (化學冷光酵素免疫分析法)
      • RIA (輻射免疫檢測)
      • 其他
    • 主要企業的市場佔有率分析
  • 微陣列
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • DNA微陣列
      • 蛋白質微陣列
      • 細胞微陣列
      • 組織微陣列
    • 主要企業的市場佔有率分析
  • 流式細胞技術
    • 成長推進因素
    • 阻礙成長要素
    • 各類型市場
      • 以細胞為基礎的流式細胞技術
      • 以微珠為基礎的流式細胞技術
      • 其他
    • 主要企業的市場佔有率分析
  • 其他設備
    • 離心機
    • 培養箱
      • 成長推進因素
      • 課題
    • 通風罩
      • 成長推進因素
      • 阻礙成長要素
    • 實驗室用天平
      • 成長推進因素
      • 課題

第8章 各終端用戶市場

  • 簡介
  • 層析法
    • 醫藥品企業、CRO
    • 生物科技、生物醫藥品企業
    • 學術研究實驗室
    • 農業、食品產業
    • 環境檢驗
    • 生物科技、生物醫藥品企業
  • 電泳
    • 醫藥品企業、CRO
    • 生物科技企業、生命科學系研究機關
    • 司法鑑定、臨床診斷實驗室
    • 學術機構
    • 其他
  • DNA定序器&增幅器
    • 醫藥品、生物科技企業、CRO
    • 研究實驗室、學術機構
    • 醫院、診斷中心
    • 司法鑑定研究所
  • 實驗室自動化
    • 醫藥品、生物科技企業、CRO
    • 醫院、民間實驗室
    • 研究機關
    • 學術機構
  • 光譜學
    • 醫藥品企業、CRO
    • 生物科技、生物醫藥品企業
    • 環境檢驗產業
    • 食品、飲料產業
    • 產業化學
    • 學術機構
    • 其他
  • 免疫測量
    • 醫院
    • 公共實驗室、民間實驗室
    • 醫藥品、生物科技企業、CRO
    • 學術機構
    • 其他
  • 微陣列
    • 醫藥品、生物醫藥品產業
    • 研究實驗室
    • 診斷實驗室
    • 學術機構
    • 其他
  • 流式細胞技術
    • 醫藥品、生物科技企業
    • 學術機構
    • 醫院
    • 醫學系
    • 臨床試驗實驗室
  • 其他
    • 醫藥品、生物醫藥品企業
    • 研究機關
    • 學術機構
    • 其他

第9章 地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭環境

  • 簡介
  • 新產品的投入
  • 協定、聯盟、合作
  • 擴張
  • 收購
  • 其他

第11章 企業簡介

  • 簡介
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • F. Hoffmann-LA Roche Ltd.
  • Perkinelmer, Inc.
  • 島津製作所
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
    • 產業概要
    • 產品系列
    • 主要策略
    • 近幾年的發展趨勢等

第12章 附錄

目錄
Product Code: BT 3282

The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the global life science and chemical instrumentation market in 2014, the Asia-Pacific region is poised to grow at the highest rate in the next five years. Factors such as strategic expansion by key market players in emerging Asian countries; growing pharmaceutical and biopharmaceutical industry; rising government investments in biomedical industry in China and Singapore, and extensive crop research in Asia to feed its increasing population are propelling the demand of the life science and chemical instrumentations in Asia-Pacific region.

The growth of the global life science and chemical instrumentation market is driven by factors such as rising pharmaceutical R&D investments in emerging countries, increasing food safety concerns, availability of public and private funding for life science research studies, advancements in analytical instruments in terms of technology, miniaturization of instruments, and stringent drug development regulations in developed countries. In addition, emerging economies and increasing demand of analytical instruments from applied markets are creating new growth opportunities for the life science and chemical instrumentation manufacturers. Nonetheless, the high cost of technologically advanced instruments, scarcity of skilled professionals, and presence of alternative analytical technologies are the key reasons hampering the growth of life science and chemical instrumentation market.

In this report, the life science and chemical instrumentation market has been segmented on the basis of technology (covering chromatography, electrophoresis, DNA sequencers & amplifiers, lab automation, spectroscopy, immunoassay, microarray, flow cytometry, and other instruments (incubators, lab balances, fume hoods, and centrifuges)), by end user (including pharmaceutical, biopharmaceutical, and biotechnology companies; clinical research organizations (CROs); research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry; among others), and by region (North America, Europe, Asia Pacific, and Rest of the World). The spectroscopy market commanded the largest share of the global life science and chemical instrumentation market in 2014. However, the DNA sequencers and amplifiers market is expected to grow at the highest rate during the forecast period. Development of technologically advanced cost efficient genome sequencers and amplifiers is the key factor driving the growth of this market segment.

Geographically, North America (comprising the U.S. and Canada) commanded the largest share of the global life science and chemical instrumentation market in 2014, followed by Europe. The North American life science and chemical instrumentation market is driven by factors such as stringent drug development regulations, public and private funding for life science research activities, growing number of metabolomics research studies, rising prevalence of chronic diseases and aging population (that is responsible for the boost in the research on bio-based drugs), and a significant number of conferences, discussions, symposium, & seminars hosted by North America related to analytical technologies. However, increasing outsourcing of clinical research by big U.S. pharma companies to developing Asian countries and changes in the Canadian R&D tax credit program are negatively affecting the growth of the life science and chemical instrumentation market in North America.

The global life science and chemical instrumentation market is fragmented and competitive with a large number of global and local manufacturers of analytical instruments. Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players in the global life science and chemical instrumentation market. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the life science and chemical instrumentation market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis -industry analysis (industry trends, and Porter's five force model), market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the life science and chemical instrumentation market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on analytical instrumentation products offered by the top 10 players in the life science and chemical instrumentation market. The report analyzes the life science and chemical instrumentation market by technology and end user across four geographies
  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, and new product launches in the life science and chemical instrumentation market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various life science and chemical instrumentations across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the life science and chemical instrumentation market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the life science and chemical instrumentation market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Limitations
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Research Data
    • 2.1.1. Secondary Data
      • 2.1.1.1. Key Data From Secondary Sources
    • 2.1.2. Primary Data
      • 2.1.2.1. Breakdown of Primaries
      • 2.1.2.2. Key Data From Primary Sources
      • 2.1.2.3. Key Industry Insights
  • 2.2. Market Size Estimation
    • 2.2.1.1. Bottom-Up Approach
    • 2.2.1.2. Top-Down Approach
  • 2.3. Market Breakdown and Data Triangulation
  • 2.4. Research Assumptions

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Current Scenario
  • 3.3. Future Outlook
  • 3.4. Conclusion

4. Premium Insights

  • 4.1. Attractive Market Opportunities in the Life Science and Chemical Instrumentation Market
  • 4.2. Top Four Life Science and Chemical Instrumentation Markets, By Region (2014)
  • 4.3. Global Life Science and Chemical Instrumentation Market, By Technology (2014-2019)

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Life Science and Chemical Instrumentation Market Segmentation, By Technology
    • 5.2.2. Life Science and Chemical Instrumentation Market Segmentation, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Increasing Government Spending on Pharmaceutical R&D in Emerging Nations
      • 5.3.1.2. Growing Food Safety Concerns
      • 5.3.1.3. Technological Advancements in Analytical Devices
      • 5.3.1.4. Funding Sources Increase Purchasing Power of the Major Research Institutions
    • 5.3.2. Restraints
      • 5.3.2.1. Presence of Alternative Technologies
      • 5.3.2.2. High Cost of Instruments
    • 5.3.3. Opportunities
      • 5.3.3.1. Rising Opportunities in Emerging Nations
      • 5.3.3.2. Growing Proteomics Market
      • 5.3.3.3. Growing Environmental Safety Concerns
      • 5.3.3.4. Opportunity for Lab Automation Solutions in Biobank Applications
      • 5.3.3.5. Increasing Demand From Applied Markets
    • 5.3.4. Challenges
      • 5.3.4.1. Extensive Requirements in Developing Chromatography Systems That Generate Pressure Above 20,000. Psi
      • 5.3.4.2. Survival of Small Players in the Lab Automation Market
      • 5.3.4.3. Adoption and Implementation of Miqe Guidelines for Publishing QPCR and DPCR - Based Research

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Value Chain Analysis
  • 6.3. Industry Trends
    • 6.3.1. Development of Miniaturized Instruments
    • 6.3.2. Increasing Adoption of Hyphenated Technologies
    • 6.3.3. Tie-Ups of Analytical Instrument Manufacturers With Research Labs and Academic Institutions
  • 6.4. Porter's Five Forces Analysis
    • 6.4.1. Threat From New Entrants
    • 6.4.2. Threat From Substitutes
    • 6.4.3. Bargaining Power of Suppliers
    • 6.4.4. Bargaining Power of Buyers
    • 6.4.5. Intensity of Competitive Rivalry

7. Life Science and Chemical Instrumentation Market, By Technology

  • 7.1. Introduction
  • 7.2. Chromatography
    • 7.2.1. Drivers
      • 7.2.1.1. New International GMP & GDP Certification for Pharmaceutical Excipients (North America & Europe): Excipact
      • 7.2.1.2. Industry Support to Research Laboratories and Academic Institutes
      • 7.2.1.3. Rise in Government Investments in Chromatography Technologies
      • 7.2.1.4. Increased Importance of Chromatography Tests in Drug Approvals
    • 7.2.2. Restraint
      • 7.2.1.1. High Cost of Instruments
    • 7.2.3. Challenge
      • 7.2.2.1. Obtaining Identical Results From Uhplc After Transfer of Hplc to Uhplc
    • 7.2.4. Chromatography Market, By Type
      • 7.2.4.1. Liquid Chromatography
      • 7.2.4.2. Gas Chromatography
      • 7.2.4.3. Other Chromatography Techniques
    • 7.2.5. Market Share Analysis, By Key Players
  • 7.3. Electrophoresis
    • 7.3.1. Drivers
      • 7.3.1.1. Preferred Technique for Fragile Molecules and Variants
      • 7.3.1.2. Increase in Demand for 2d Gel Electrophoresis
      • 7.3.1.3. Lab-On-A-Chip (LOC) Technology
    • 7.3.2. Restraint
      • 7.3.2.1. Alternative Technologies Provide Better Results
    • 7.3.3. Electrophoresis Market, By Type
      • 7.3.3.1. Gel Electrophoresis
      • 2.3.3.2. Capillary Electrophoresis
    • 7.3.4. Market Share Analysis, By Key Players
  • 7.4. DNA Sequencers & Amplifiers
    • 7.4.1. Drivers
      • 7.4.1.1. Technological Advancements
      • 7.4.1.2. Increasing Public and Private Investments, Funds, and Grants
      • 7.4.1.3. Rising Incidence of Infectious Diseases and Genetic Disorders
    • 7.4.2. Restraint
      • 7.4.2.1. High Cost of Equipment
    • 7.4.3. DNA Sequencers & Amplifiers Market, By Type
      • 7.4.3.1. DNA Sequencers
      • 7.4.3.2. DNA Amplifiers
        • 7.4.3.2.1. Thermal Cyclers
        • 7.4.3.2.2. Real-Time PCR
        • 7.4.3.2.3. Others
    • 7.4.4. Market Share Analysis, By Key Players
  • 7.5. Lab Automation
    • 7.5.1. Drivers
      • 7.5.1.1. Process Miniaturization Leading to Low Reagent Cost and High Productivity
      • 7.5.1.2. Progress in Drug Discovery and Clinical Diagnostics
      • 7.5.1.3. Large Workforce Demand and Supply Gap
      • 7.5.1.4. Greater Productivity and Reduction in Costs
      • 7.5.1.5. Smaller Volumes of Samples and Reagents Required
    • 7.5.2. Restraints
      • 7.5.2.1. Automation Not A Priority for Small- and Medium-Sized Labs
      • 7.5.2.2. Indefinite Data Interchange/Communication Standards
    • 7.5.3. Lab Automation Market, By Type
      • 7.5.3.1. Automatic Liquid Handling
      • 7.5.3.2. Microplate Readers
      • 7.5.3.3. Standalone Robots
      • 7.5.3.4. Automated Storage and Retrieval Systems
      • 7.5.3.5. Software and Informatics
      • 7.5.3.6. Others
    • 7.5.4. Market Share Analysis, By Key Players
  • 7.6. Spectroscopy
    • 7.6.1. Drivers
      • 7.6.1.1. Global Alliances Amongst Leading Research Institutes to Boost Drug Discovery
      • 7.6.1.2. Atomic Absorption Spectroscopy to Aid in the Drug Safety Process
      • 7.6.1.3. Increasing Life Science R&D Spending
    • 7.6.2. Restraints
      • 7.6.2.1. High Costs Restrict Purchase
      • 7.6.2.2. Need for Skilled Professionals
    • 7.6.3. Spectroscopy Market, By Type
      • 7.6.3.1. Molecular Spectroscopy
      • 7.6.3.2. Atomic Spectroscopy
      • 7.6.3.3. Mass Spectrometry
    • 7.6.4. Market Share Analysis, By Key Players
  • 7.7. Immunoassay
    • 7.7.1. Drivers
      • 7.7.1.1. Rising Incidence of Chronic and Infectious Diseases
      • 7.7.1.2. Increasing Number of Approvals for Immunoassay Techniques
      • 7.7.1.3. Advantages Such as High Sensitivity, Low Cost, and Faster Turnaround Times
      • 7.7.1.4. Increasing Health Awareness
    • 7.7.2. Restraints
      • 7.7.2.1. Low Detection Restricts Adoption of Immunoassay Tests
      • 7.7.2.2. Pricing Pressure for Some Tests Due to Competition From Lower Cost-Per-Test Technologies
    • 7.7.3. Immunoassay Market, By Type
      • 7.7.3.1. Enzyme Immunoassay (EIA)
      • 7.7.3.2. Fluorescence Immunoassay (FIA)
      • 7.7.3.3. Chemiluminescence Immunoassay (Clia)
      • 7.7.3.4. Radioimmunoassay (RIA)
      • 7.7.3.5. Others
    • 7.7.4. Market Share Analysis, By Key Players
  • 7.8. Microarray
    • 7.8.1. Drivers and Opportunities
      • 7.8.1.1. Growth in Personalized Medicine
      • 7.8.1.2. Technological Advances
      • 7.8.1.3. Increasing Application Areas
    • 7.8.2. Restraint
      • 7.8.2.1. Lack of Technical Know-How
    • 7.8.3. Microarrays Market, By Type
      • 7.8.3.1. DNA Microarrays
      • 7.8.3.2. Protein Microarrays
      • 7.8.3.3. Cell Microarrays
      • 7.8.3.4. Tissue Microarrays
    • 7.8.4. Market Share Analysis, By Key Players
  • 7.9. Flow Cytometry
    • 7.9.1. Drivers
      • 7.9.1.1. Technological Advancements in Flow Cytometry Instruments
      • 7.9.1.2. Fostering Use of Flow Cytometry Techniques in Research Activities
      • 7.9.1.3. Increasing Use of Flow Cytometry in Clinical Trials
      • 7.9.1.4. Increasing Use of Flow Cytometry in Hiv and Cancer Research
      • 7.9.1.5. Launch of New Reagents for Specific Applications Like Diagnostics and Drug Discovery
    • 7.9.2. Restraints
      • 7.9.2.1. High Cost of Instruments
      • 7.9.2.2. Reluctance Among Researchers in Emerging Countries to Use Flow Cytometry
      • 7.9.2.3. Lack of Awareness and Dearth of Training
    • 7.9.3. Flow Cytometry Market, By Type
      • 7.9.3.1. Cell-Based Flow Cytometry
      • 7.9.3.2. Bead-Based Flow Cytometry
      • 7.9.3.3. Others
    • 7.9.10. Market Share Analysis, By Key Players
  • 7.1. Other Instruments
    • 7.10.1. Centrifuges
    • 7.10.2. Incubators
      • 7.10.2.1. Drivers
        • 7.10.2.1.1. Genetic Engineering Will Drive the Market
        • 7.10.2.1.2. Stem Cells and Biological Therapeutics Increase the Demand for Co2 Incubators
      • 7.10.2.2. Challenge
        • 7.10.2.2.1. Contamination - A Major Concern
    • 7.10.3. Fume Hoods
      • 7.10.3.1. Driver
        • 7.10.3.1.1. Improvements in Device Structure
      • 7.10.3.2. Restraint
        • 7.10.3.2.1. High Electricity Consumption
    • 7.10.4. Laboratory Balances
      • 7.10.4.1. Driver
        • 7.10.4.1.1. Technological Advancements in Laboratory Balances
      • 7.10.4.2. Challenge
        • 7.10.4.2.1. Effect of Environmental Disturbances

8. Life Science and Chemical Instrumentation Market, By End User

  • 8.1. Introduction
  • 8.2. Chromatography
    • 8.2.1. Pharmaceutical Companies and Cros
    • 8.2.2. Biotechnology and Biopharmaceutical Companies
    • 8.2.3. Academic Research Laboratories
    • 8.2.4. Agriculture & Food Industry
    • 8.2.5. Environmental Testing
    • 8.2.6. Biotechnology and Biopharmaceutical Companies
  • 8.3. Electrophoresis
    • 8.3.1. Pharmaceutical Companies and Cros
    • 8.3.2. Biotechnology Companies and Life Science Research Institutions
    • 8.3.3. Forensic Science and Clinical Diagnostic Laboratories
    • 8.3.4. Academic Institutions
    • 8.3.5. Others
  • 8.4. DNA Sequencers & Amplifiers
    • 8.4.1. Pharma and Biotech Companies, and Cros
    • 8.4.2. Research Laboratories and Academic Institutes
    • 8.4.3. Hospitals and Diagnostic Centers
    • 8.4.4. Forensic Laboratories
  • 8.5. Lab Automation
    • 8.5.1. Pharma and Biotech Companies, and Cros
    • 8.5.2. Hospitals and Private Labs
    • 8.5.3. Research Institutions
    • 8.5.4. Academic Institutions
  • 8.6. Spectroscopy
    • 8.6.1. Pharmaceutical Companies and Cros
    • 8.6.2. Biotechnology and Biopharmaceutical Companies
    • 8.6.3. Environmental Testing Industry
    • 8.6.4. Food and Beverage Industry
    • 8.6.5. Industrial Chemistry
    • 8.6.6. Academic Institutions
    • 8.6.7. Others
  • 8.7. Immunoassay
    • 8.7.1. Hospitals
    • 8.7.2. Public and Private Laboratories
    • 8.7.3. Pharmaceutical and Biotech Companies, and Cros
    • 8.7.4. Academic Institutions
    • 8.7.5. Others
  • 8.8. Microarray
    • 8.8.1. Pharmaceutical and Biopharmaceutical Industry
    • 8.8.2. Research Laboratories
    • 8.8.3. Diagnostic Laboratories
    • 8.8.4. Academic Institutions
    • 8.8.5. Others
  • 8.9. Flow Cytometry
    • 8.9.1. Pharmaceutical and Biotechnology Companies
    • 8.9.2. Academic Institutions
    • 8.9.3. Hospitals
    • 8.9.4. Medical Schools
    • 8.9.5. Clinical Testing Labs
  • 8.1. Other Instrumentation
    • 8.10.1. Pharmaceutical and Biopharmaceutical Companies
    • 8.10.2. Research Institutions
    • 8.10.3. Academic Institutions
    • 8.10.4. Others

9. Geographic Analysis

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. Funding in Medical Research May Develop New Application Areas for Analytical Technologies
    • 9.2.2. North America Drug Development Regulation to Trigger the Market Growth
    • 9.2.3. Growing Metabolomics Researches in U.S. to Increase the Demand of Analytical Instrumentation
    • 9.2.4. Conferences, Discussions, Symposium, & Seminars Hosted By North America Related to Analytical Technologies to Propel the Growth
    • 9.2.5. Rising Prevalence of Chronic Diseases and Aging Population in the North America Region is Boosting the Research on Bio-Based Drugs
  • 9.3. Europe
    • 9.3.1. Direct and Indirect Financial Investments in the Analytical Instruments to Bolster the Growth
    • 9.3.2. Strategic Alliances in Europe to Trigger the Growth of Drug Discovery
    • 9.3.3. Burgeoning Growth in the European Biosimilars Market is Fuelling the Market Growth
    • 9.3.4. Conferences and Symposia Hosted By Europe to Propel the Market Growth
    • 9.3.5. Developing Pharmaceutical Sector in Russia Likely to Boost the Life Science and Chemical Instrumentation Market
  • 9.4. Asia-Pacific
    • 9.4.1. Strategic Expansion By Key Market Players in Emerging Asian Countries is Propelling the Market Growth
    • 9.4.2. Growing Pharmaceutical Industry in India and China to Increase the Demand for Life Science and Chemical Instrumentation
    • 9.4.3. Extensive Crop Research in Asia to Feed It's Growing Population is Driving the Market Growth
    • 9.4.4. Government Investment in Biomedical Industry in China to Increase the Market Growth
    • 9.4.5. Infrastructural Development in Vietnam Expected to Stimulate the Market Growth
    • 9.4.6. Singapore - an Important Market for the Life Science and Chemical Instrumentation
    • 9.4.7. Conferences, Exhibitions & Meetings on Analytical Instruments to Increase the Business Relation in Asia-Pacific
  • 9.5. Rest of the World
    • 9.5.1. Flourishing Biotechnology & Pharmaceutical Markets in Brazil and Mexico to Bolster the Growth of the Market
    • 9.5.2. Increasing R&D Funding in the Latin American Region to Stimulate the Market Growth
    • 9.5.3. High Prevalence of Hiv in African Region is Likely to Open New Growth Potential for the Lab Automation, Immunoassay, and PCR Markets

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. New Product Launches
  • 10.3. Agreements, Partnerships, and Collaborations
  • 10.4. Expansions
  • 10.5. Acquisitions
  • 10.6. Other Developments

11. Company Profiles

  • 11.1. Introduction
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Business Overview
    • 11.2.2. Product Portfolio
    • 11.2.3. Key Strategy
    • 11.2.4. Key Developments
  • 11.3. Becton, Dickinson and Company
    • 11.3.1. Business Overview
    • 11.3.2. Product Portfolio
    • 11.3.3. Key Strategy
    • 11.3.4. Key Developments
  • 11.4. Bio-Rad Laboratories, Inc.
    • 11.4.1. Business Overview
    • 11.4.2. Product Portfolio
    • 11.4.3. Key Strategy
    • 11.4.4. Key Developments
  • 11.5. Bruker Corporation
    • 11.5.1. Business Overview
    • 11.5.2. Product Portfolio
    • 11.5.3. Key Strategy
    • 11.5.4. Key Developments
  • 11.6. Danaher Corporation
    • 11.6.1. Business Overview
    • 11.6.2. Product Portfolio
    • 11.6.3. Key Strategy
    • 11.6.4. Key Developments
  • 11.7. F. Hoffmann-LA Roche Ltd.
    • 11.7.1. Business Overview
    • 11.7.2. Product Portfolio
    • 11.7.3. Key Strategy
    • 11.7.4. Key Developments
  • 11.8. Perkinelmer, Inc.
    • 11.8.1. Business Overview
    • 11.8.2. Product Portfolio
    • 11.8.3. Key Strategy
    • 11.8.4. Key Developments
  • 11.9. Shimadzu Corporation
    • 11.9.1. Business Overview
    • 11.9.2. Product Portfolio
    • 11.9.3. Key Strategy
    • 11.9.4. Key Developments
  • 11.10. Thermo Fisher Scientific, Inc.
    • 11.10.1. Business Overview
    • 11.10.2. Product Portfolio
    • 11.10.3. Key Strategy
    • 11.10.4. Key Developments
  • 11.11. Waters Corporation
    • 11.11.1. Business Overview
    • 11.11.2. Product Portfolio
    • 11.11.3. Key Strategy
    • 11.11.4. Key Developments

12. Appendix

  • 12.1. Discussion Guide*
  • 12.2. Introducing RT: Real-Time Market Intelligence
  • 12.3. Available Customizations
  • 12.4. Related Reports

List of Tables

  • Table 1: Global Life Science and Chemical Instrumentation Market Size, By Technology, 2012-2019 ($Million)
  • Table 2: Chromatography Market Size, By Technology, 2012-2019 ($Million)
  • Table 3: Chromatography Market Size, By Region, 2012-2019 ($Million)
  • Table 4: Liquid Chromatography Market Size, By Region, 2012-2019 ($Million)
  • Table 5: Gas Chromatography Market Size, By Region, 2012-2019 ($Million)
  • Table 6: Other Chromatography Techniques Market Size, By Region, 2012-2019 ($Million)
  • Table 7: Global Electrophoresis Market Size, By Technology, 2012-2019 ($Million)
  • Table 8: Electrophoresis Market Size, By Region, 2012-2019 ($Million))
  • Table 9: Gel Electrophoresis Market Size, By Region, 2012-2019 ($Million)
  • Table 10: Capillary Electrophoresis Market Size, By Region, 2012- 2019 ($Million)
  • Table 11: Global DNA Sequencers & Amplifiers Market Size, By Type, 2012-2019 ($Million)
  • Table 12: DNA Sequencers Market Size, By Region, 2012-2019 ($Million)
  • Table 13: Global Amplifiers Market Size, By Product, 2012-2019 ($Million)
  • Table 14: Amplifiers Market Size, By Region, 2012-2019 ($Million)
  • Table 15: Thermo Cyclers Market Size, By Region, 2012-2019 ($Million)
  • Table 16: Real-Time PCR Market Size, By Region, 2012- 2019 ($Million)
  • Table 17: Other Amplifiers Market Size, By Region, 2012- 2019 ($Million)
  • Table 18: Global Lab Automation Market Size, By Product, 2012-2019 ($Million)
  • Table 19: Lab Automation Market Size, By Region, 2012-2019 ($Million)
  • Table 20: Automated Liquid Handling Market Size, By Region, 2012-2019 ($Million)
  • Table 21: Micro plate Readers Market Size, By Region, 2012-2019 ($Million)
  • Table 22: Standalone Robots Market Size, By Region, 2012-2019 ($Million)
  • Table 23: Automated Storage and Retrieval Systems Market Size, By Region, 2012-2019 ($Million)
  • Table 24: Software and Informatics Market Size, By Region, 2012-2019 ($Million)
  • Table 25: Other Lab Automation Equipment and Software Market Size, By Region, 2012-2019 ($Million)
  • Table 26: Global Spectroscopy Market Size, By Technology, 2012-2019 ($Million)
  • Table 27: Spectroscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 28: Molecular Spectroscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 29: Atomic Spectroscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 30: Mass Spectrometry Market Size, By Region, 2012-2019 ($Million)
  • Table 31: Global Immunoassay Market Size, By Technology, 2012-2019 ($Million)
  • Table 32: Immunoassay Market Size, By Region, 2012-2019 ($Million)
  • Table 33: Enzyme Immunoassay Market Size, By Region, 2012-2019 ($Million)
  • Table 34: Fluorescence Immunoassay Market Size, By Region, 2012-2019 ($Million)
  • Table 35: Chemiluminescence Immunoassay Market Size, By Region, 2012-2019 ($Million)
  • Table 36: Radioimmunoassay Market Size, By Region, 2012-2019 ($Million)
  • Table 37: Other Immunoassays Market Size, By Region, 2012-2019 ($Million)
  • Table 38: Global Microarray Market Size, By Type, 2012-2019 ($Million)
  • Table 39: Microarray Market Size, By Region, 2012-2019 ($Million)
  • Table 40: DNA Microarray Market Size, By Region, 2012-2019 ($Million)
  • Table 41: Protein Microarray Market Size, By Region, 2012-2019 ($Million)
  • Table 42: Cell Microarray Market Size, By Region, 2012-2019 ($Million)
  • Table 43: Tissue Microarray Market Size, By Region, 2012-2019 ($Million)
  • Table 44: Global Flow Cytometry Market Size, By Technology, 2012-2019 ($Million)
  • Table 45: Flow Cytometry Market Size, By Region, 2012-2019 ($Million)
  • Table 46: Cell-Based Flow Cytometry Market Size, By Region, 2012-2019 ($Million)
  • Table 47: Bead-Based Flow Cytometry Market Size, By Region, 2012-2019 ($Million)
  • Table 48: Other Flow Cytometry Technologies Market Size, By Region, 2012-2019 ($Million)
  • Table 49: Global Other Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 50: Centrifuges Market Size, By Region, 2012-2019 ($Million)
  • Table 51: Laboratory Balances Market Size, By Region, 2012-2019 ($Million)
  • Table 52: Incubators Market Size, By Region, 2012-2019 ($Million)
  • Table 53: Fume Hoods Market Size, By Region, 2012-2019 ($Million)
  • Table 54: Life Science and Chemical Instrumentation Market Size, By Region, 2012-2019 ($Million)
  • Table 55: North America: Life Science and Chemical Instrumentation Market Size, By Technology, 2012-2019 ($Million)
  • Table 56: North America: Chromatography Market Size, By Technology, 2012-2019 ($Million)
  • Table 57: North America: Electrophoresis Market Size, By Technology, 2012-2019 ($Million)
  • Table 58: North America: DNA Sequencers & Amplifiers Market Size, By Type, 2012-2019 ($Million)
  • Table 59: North America: Lab Automation Market Size, By Product, 2012-2019 ($Million)
  • Table 60: North America: Spectroscopy Market Size, By Technology, 2012-2019 ($Million)
  • Table 61: North America: Immunoassay Market Size, By Technology, 2012-2019 ($Million)
  • Table 62: North America: Microarray Market Size, By Type, 2012-2019 ($Million)
  • Table 63: North America: Flow Cytometry Market Size, By Technology, 2012-2019 ($Million)
  • Table 64: North America: Other Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 65: Europe: Life Science and Chemical Instrumentation Market Size, By Technology, 2012-2019 ($Million)
  • Table 66: Europe: Chromatography Market Size, By Technology, 2012-2019 ($Million)
  • Table 67: Europe: Electrophoresis Market Size, By Technology, 2012-2019 ($Million)
  • Table 68: Europe: DNA Sequencers & Amplifiers Market Size, By Type, 2012-2019 ($Million)
  • Table 69: Europe: Lab Automation Market Size, By Product, 2012-2019 ($Million)
  • Table 70: Europe: Spectroscopy Market Size, By Technology, 2012-2019 ($Million)
  • Table 71: Europe: Immunoassay Market Size, By Technology, 2012-2019 ($Million)
  • Table 72: Europe: Microarray Market Size, By Type, 2012-2019 ($Million)
  • Table 73: Europe: Flow Cytometry Market Size, By Technology, 2012-2019 ($Million)
  • Table 74: Europe: Other Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 75: Asia-Pacific: Life Science and Chemical Instrumentation Market Size, By Technology, 2012-2019 ($Million)
  • Table 76: Asia-Pacific: Chromatography Market Size, By Technology, 2012-2019 ($Million)
  • Table 77: Asia-Pacific: Electrophoresis Market Size, By Technology, 2012-2019 ($Million)
  • Table 78: Asia-Pacific: DNA Sequencers & Amplifiers Market Size, By Type, 2012-2019 ($Million)
  • Table 79: Asia-Pacific: Lab Automation Market Size, By Product, 2012-2019 ($Million)
  • Table 80: Asia-Pacific: Spectroscopy Market Size, By Technology, 2012-2019 ($Million)
  • Table 81: Asia-Pacific: Immunoassay Market Size, By Technology, 2012-2019 ($Million)
  • Table 82: Asia-Pacific: Microarray Market Size, By Type, 2012-2019 ($Million)
  • Table 83: Asia-Pacific: Flow Cytometry Market Size, By Technology, 2012-2019 ($Million)
  • Table 84: Asia-Pacific: Other Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 85: RoW: Life Science and Chemical Instrumentation Market Size, By Technology, 2012-2019 ($Million)
  • Table 86: RoW: Chromatography Market Size, By Technology, 2012-2019 ($Million)
  • Table 87: RoW: Electrophoresis Market Size, By Technology, 2012-2019 ($Million)
  • Table 88: RoW: DNA Sequencers & Amplifiers Market Size, By Type, 2012-2019 ($Million)
  • Table 89: RoW: Lab Automation Market Size, By Product, 2012-2019 ($Million)
  • Table 90: RoW: Spectroscopy Market Size, By Technology, 2012-2019 ($Million)
  • Table 91: RoW: Immunoassay Market Size, By Technology, 2012-2019 ($Million)
  • Table 92: RoW: Microarray Market Size, By Type, 2012-2019 ($Million)
  • Table 93: RoW: Flow Cytometry Market Size, By Technology, 2012-2019 ($Million)
  • Table 94: RoW: Other Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 95: Top 5 New Product Launches, 2012-2014
  • Table 96: Top 5 Agreements, Partnerships, and Collaborations, 2012-2014
  • Table 97: Top 5 Geographical Expansions, 2012-2014
  • Table 98: Top 5 Acquisitions, 2012-2014
  • Table 99: Top 5 Other Developments, 2012-2014

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Break Down of Supply Side Primary Interviews: By Company Type, Designation, and Region
  • Figure 3: Life Science and Chemical Instrumentation Market: Bottom Up Approach
  • Figure 4: Market: Top-Down Approach
  • Figure 5: Market: Data Triangulation
  • Figure 6: Global Life Science and Chemical Instrumentation Market, 2014 ($Million)
  • Figure 7: Life Science and Chemical Instrumentation Global Market, 2014 vs. 2019
  • Figure 1: Life Science and Chemical Instrumentation Global Market, By Region, 2014 ($Million)
  • Figure 1: Life Science and Chemical Instrumentation Market Segmentation
  • Figure 12: Segmentation, By Technology
  • Figure 13: Market Segmentation, By End User
  • Figure 14: Drivers, Restraints, Opportunities, & Challenges
  • Figure 15: Market Players Prefer Both Direct & Indirect Distribution Strategies
  • Figure 16: Porter's Five Forces Analysis, 2014
  • Figure 17: Life Science and Chemical Instrumentation Market, By Technology, 2014 vs. 2019 ($Million): DNA Sequencers & Amplifiers Market to Grow at the Fastest Rate
  • Figure 18: Global Electrophoresis Market, By Technology, 2014 vs. 2019
  • Figure 19: Burgeoning Prevalence of HIV Worldwide Will Boost the Adoption of PCR
  • Figure 20: Global Lab Automation Market, By Product, 2014 vs. 2019
  • Figure 21: Information Flow Pyramid
  • Figure 22: Global Spectroscopy Market, By Technology, 2014 vs. 2019
  • Figure 23: Global Immunoassay Market, By Technology, 2014 vs. 2019
  • Figure 24: Global Prevalence of Cancer
  • Figure 25: Global Distribution of Cardiovascular Mortality Rates Among Males, 2011
  • Figure 26: Global Distribution of Cardiovascular Mortality Rates Among Females, 2011
  • Figure 27: Global Flow Cytometry Market, By Technology, 2014 vs. 2019
  • Figure 28: Life Science and Chemical Instrumentation Market, By Region, 2014 vs. 2019 ($Million): Asia-Pacific to Grow at the Highest Rate During the Forecast Period
  • Figure 29: North American Life Science and Chemical Instrumentation Market Snapshot (2014-2019)
  • Figure 30: European Life Science and Chemical Instrumentation Market Snapshot (2014-2019)
  • Figure 31: Asia-Pacific Life Science and Chemical Instrumentation Market Snapshot (2014-2019)
  • Figure 32: Leading Market Players Adopted New Product Launches as Their Key Growth Strategy in 2014
  • Figure 33: Battle for Market Share: New Product Launches is the Key Strategy
  • Figure 34: Geographic Revenue Mix of Top 5 Market Players
  • Figure 35: Agilent Technologies, Inc.: Company Snapshot
  • Figure 36: Becton, Dickinson and Company: Company Snapshot
  • Figure 37: Bio-Rad Laboratories, Inc.: Company Snapshot
  • Figure 38: Bruker Corporation: Company Snapshot
  • Figure 39: Danaher Corporation: Company Snapshot
  • Figure 40: F. Hoffmann-LA Roche Ltd.: Company Snapshot
  • Figure 41: Perkinelmer, Inc.: Company Snapshot
  • Figure 42: Shimadzu Corporation: Company Snapshot
  • Figure 43: Thermo Fisher Scientific, Inc.: Company Snapshot
  • Figure 44: Waters Corporation: Company Snapshot
Back to Top